See exactly what 10,000+ investors receive every week.
FireStrike Weekly
Issue #47 · Jan 13, 2026
Early-stage biotechs feel the squeeze as funding favors derisked assets, with Parabilis Medicines raising $305M in one of the largest biotech deals this quarter. BioSpace has more here.
U.S. venture-capital fundraising falls 35% as firms stay private longer Yahoo Finance has more here.
More money, fewer winners: Inside venture capital's uneven comeback The Street has more here.
Parabilis Medicines
Series ABiotech firm focusing on derisked assets in therapeutics.
Raised $305M · Biotech · High-growth potential
Cambium
Series BAdvanced materials startup.
Raised $100M · Materials Tech · Expanding operations
Pomelo Care
Series AMaternal health tech platform.
Raised $92M · HealthTech · Scaling services
Trybe – Spa and wellness management platform. Raised $30M Series A from Five Elms Capital.
Basecamp Research – AI lab for new medicines. Investment from NVIDIA's NVentures.
Bluecopa – AI-native finance operations. Raised $7.5M Series A led by Analog.
Parabilis Medicines, a biotech startup, raised a $305M Series A amid focus on derisked assets. BioSpace has more here.
Rain, a stablecoin-linked payment infrastructure startup, raised a $250M Series C at $1.95B valuation Led by ICONIQ with Sapphire, Dragonfly, Bessemer, and others. FinTech Futures has more here.
Cambium, an advanced materials company, raised a $100M round AlleyWatch has more here.
Full metrics: ARR, growth rate, team background
Why it matters, market positioning, red flags
Funding trends, notable deals, M&A activity
Email intros for serious investors
Join 10,000+ investors who never miss a trending startup.